RT @IUCancerCenter: In 1974, the survival rate for testicular cancer was just 5%. Today, thanks to the groundbreaking work of Lawrence Einh…

RT @nabiladra: Patients with relapsed germ cell tumors with progressive brain metastases are curable with multimodal therapy which includes…

RT @IMG_Oncologists: 🚀 Brilliant poster presentation by @rebeccahassoun on longitudinal evaluation of ctNA as a prognostic biomarker to det…

Our amazing 1st yr fellow @AhmedBilalKhal2 presenting pts with stage 1 NSGCT on active surveillance w/ RP only relapse treated with chemo vs RPLND. Important features of pts carefully selected for RPLND: ☑️Normal tumor markers ☑️RP LNs <3cm ☑️ Longer duration prior to relapse

@AnnaGaddy @IUCancerCenter @JenSchwartzIUSM Hilton city center. I didn’t realize you were in Milwaukee now- hope all is well!

RT @DrYukselUrun: Pegfilgrastim in metastatic germ-cell tumor treatment with bleomycin shows no increased risk for lung toxicity. @Indiana…

RT @nabiladra: Safety of pegfilgastrim in patients with germ cell tumors treated with bleomycin-containing regimens. No increased risk of l…

RT @nabiladra: @rebeccahassoun presenting initial results for ctDNA monitoring in patients with stage II/III non-seminomatous GCT. Need to…

RT @OncLive: 🧬 ctDNA making progress to evaluate cancer recurrence for Stage II and Stage III non seminoma germ cell tumors #GU24 @CParkM…

Our superstar @IUHemOnc fellow @AhmedBilalKhal2 and his work on BMI and outcomes in GCT patient treated with HDCT 👏 @IUCancerCenter @nabiladra #GU24

RT @nabiladra: @IUCancerCenter GU oncology group at #GU24 Proud to be part of this great team! @JenniferKingMD @SalousTareq @ClintCaryMD @r…

RT @hoosiercancer: We have more work to share at @asco -GU. Tomorrow, 1/27 8-10am join us at TIP Poster Session C: TPS492 Poster Board M13.…

RT @nabiladra: GU post doc @rebeccahassoun from @IUCancerCenter presenting real world data for predictors of PSA response to PSMA Lu-177 in…

RT @IUHemOnc: We are very excited to welcome our new class of fellows matched @IUHemOnc Congratulations! We are THRILLED to have you join u…

RT @JAMAOnc: Teratoma in the primary tumor or in post-chemotherapy residual non-retroperitoneal disease is not associated with inferior sur…

RT @nabiladra: @IUCancerCenter @JenniferKingMD

RT @TarahBallinger: Kudos to @nabiladra for leading and organizing @IUCancerCenter 30th anniversary ASCO review 🙌🏼

RT @nabiladra: Join us this Saturday July 15 for the 30th Anniversary of the IU Review & Interpretation of the ASCO Meeting. We have a grea…

RT @OncLive: Teratoma in the primary tumor site was associated with a higher incidence of teratoma in residual nonretroperitoneal (non–RP)…